Rotavirus particles with chimeric surface proteins

Patent metadata

Field	Value
Publication number	US-10192025-B2
Application number	US-201414900829-A
Country	US
Kind code	B2
Filing date	Jul 8, 2014
Priority date	Jul 8, 2013
Publication date	Jan 29, 2019
Grant date	Jan 29, 2019

Abstract

The present invention relates to the use of rotavirus particles for displaying a heterologous protein, alone or in complex with another molecule. The invention further relates to methods that employ these modified rotavirus particles to rapidly determine the structure of the heterologous protein or the complex using cryo-electron microscopy (cryo-EM). The invention also relates to a method of immunizing a patient, wherein said method comprises administering to the patient the modified rotavirus particles of the invention.

First claim

The invention claimed is:

1. A chimeric protein complex comprising a trimer-forming rotavirus VP7 surface protein linked to a heterologous protein, wherein the rotavirus VP7 surface protein is linked to the heterologous protein non-covalently by a two-part adapter system, wherein the first part of the adapter system comprises a first adapter polypeptide that is fused to the rotavirus VP7 surface protein optionally via a linker sequence, and the second part of the adapter system comprises a second adapter polypeptide that is fused to the heterologous protein optionally via a linker sequence, wherein the first and the second parts of the adapter system form a stable complex with each other, and wherein the chimeric protein complex is capable of recoating and thereby forming a part of an outer layer of double-layered rotavirus particles in vitro.

2. The chimeric protein complex of claim 1 , wherein the first adapter polypeptide and the second adapter polypeptide comprise a heptad repeat sequence.

3. A rotavirus particle comprising the chimeric protein complex of claim 1 .

4. A formulation comprising a rotavirus particle of claim 3 and a solution, optionally together with an excipient.

5. A nucleic acid composition comprising:
(a) an open reading frame encoding a modified rotavirus surface protein comprising
a trimer-forming rotavirus VP7 surface protein,
a first adapter polypeptide that is fused to the trimer-forming rotavirus VP7 surface protein optionally via a linker sequence; and

(b) an open reading frame encoding a fusion protein comprising
a protein that is heterologous to the trimer-forming rotavirus VP7 surface protein,
a second adapter polypeptide that is fused to the heterologous protein optionally via a linker sequence,
wherein the first and the second adapter polypeptides form a stable protein complex with each other; and

(c) optionally a promoter sequence that is operationally linked to the open reading frame of (a) and further optionally a promoter sequence that is operationally linked to the open reading frame of (b).

6. The nucleic acid composition of claim 5 , wherein the adapter polypeptide comprises a heptad repeat sequence.

7. A kit comprising:
(a) a first nucleic acid encoding a modified rotavirus surface protein comprising a trimer-forming rotavirus VP7 surface protein and a first adapter polypeptide, and a second nucleic acid comprising a nucleotide sequence encoding a second adapter polypeptide and a multiple cloning site, and wherein insertion of a coding region for a heterologous protein in the multiple cloning site yields an open reading frame encoding a fusion protein comprising the heterologous protein and the second adapter polypeptide; or
(b) a first nucleic acid encoding a modified rotavirus surface protein comprising a trimer-forming rotavirus VP7 surface protein and a first adapter polypeptide and a second nucleic acid encoding a fusion protein comprising a heterologous protein and a second adapter polypeptide;
wherein, in each case (a) and (b), the first adapter polypeptide and the second adapter polypeptide are able to form a stable protein complex,
optionally wherein the kit further comprises a rotavirus particle, wherein the particle is from the same species of rotavirus as the rotavirus from which the trimer-forming VP7 surface protein originated or from a different rotavirus species.

8. A method for preparing the rotavirus particle of claim 3 , wherein the method comprises propagating a rotavirus particle comprising an outer layer in a cell grown in a culture medium, purifying the rotavirus particle from the culture medium, removing the outer layer from the rotavirus particle to obtain a rotavirus double-layered particle (DLP), and recoating the rotavirus DLP with the chimeric protein complex of claim 1 to yield the rotavirus particle of claim 3 .

9. A method for preparing the rotavirus particle of claim 3 , wherein the method comprises propagating a rotavirus particle comprising an outer layer in a cell grown in a culture medium, purifying the rotavirus particle from the culture medium, removing the outer layer from the rotavirus particle to obtain a rotavirus DLP, and recoating the rotavirus DLP with a first fusion protein comprising a trimer-forming rotavirus VP7 surface protein, a first adapter polypeptide comprising a heptad repeat sequence, and optionally a linker sequence and mixing the recoated rotavirus DLP with a second fusion protein comprising a trimer-forming heterologous protein, a second adapter polypeptide comprising a heptad repeat sequence, and optionally a linker sequence to yield the rotavirus particle of claim 3 .

10. A method for preparing the rotavirus particle of claim 3 comprising mixing a rotavirus particle comprising a first fusion protein comprising a trimer-forming rotavirus VP7 surface protein, a first adapter polypeptide comprising a heptad repeat sequence, and optionally a linker sequence with a second fusion protein comprising a trimer-forming heterologous protein, a second adapter polypeptide comprising a heptad repeat sequence, and optionally a linker sequence to yield the rotavirus particle of claim 3 .

11. A method for determining a structure of a heterologous protein, wherein the method comprises the steps of (i) recoating a rotavirus double-layered particle (DLP) with the chimeric protein complex of claim 1 to yield a suspension of rotavirus particles displaying the chimeric protein complex, (ii) freezing the suspension, (iii) imaging the rotavirus particles using cryo-EM to obtain a plurality of micrographs, and (iv) analysing the plurality of micrographs to obtain a three-dimensional model of the chimeric protein complex.

12. A method for determining a structure of a heterologous protein in complex with a molecule, wherein the method comprises the steps of (i) recoating a rotavirus double-layered particle (DLP) with the chimeric protein complex of claim 1 to yield a suspension of rotavirus particles displaying the chimeric protein complex, (ii) adding to the suspension a molecule that specifically binds to the heterologous protein, wherein the molecule forms a complex with the chimeric protein complex, (iii) freezing the suspension, (iv) imaging the rotavirus particles using cryo-EM to obtain a plurality of micrographs, and (vi) analysing the plurality of micrographs to obtain a three-dimensional model of the chimeric surface protein comprising all or part of the heterologous protein complexed to the molecule.

13. The method of claim 12 , wherein the molecule is a proteinaceous molecule.

14. The method of claim 13 , wherein the proteinaceous molecule is (a) an antibody or fragment thereof, wherein the antibody or fragment specifically binds the heterologous protein; or (b) a cell surface receptor, wherein the heterologous protein is a viral cell entry protein and the proteinaceous molecule is bound by the viral cell entry protein.

Assignees

• Novartis Ag
• Childrens Medical Center
• Univ Brandeis

Inventors

• Dormitzer Philip R
• Grigorieff Nikolaus
• Harrison Stephen
• Pan Junhua
• Settembre Ethan

Classifications

• A61P37/04

  Immunostimulants · CPC title

• C12N7/00

  Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title

• C07K14/14 Primary

  Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus · CPC title

• C07K14/005

  from viruses · CPC title

• C07K2319/73

  containing coiled-coiled motif (leucine zippers) · CPC title